Evidence map›Paper›PMID 19996317›Full record

ArticleThe Journal of biological chemistry2010

Transforming growth factor beta1 inhibits cystic fibrosis transmembrane conductance regulator-dependent cAMP-stimulated alveolar epithelial fluid transport via a phosphatidylinositol 3-kinase-dependent mechanism.

Jérémie Roux, Michel Carles, Hidefumi Koh, Arnaud Goolaerts, Michael T Ganter, Brian B Chesebro, Marybeth Howard, Benjamin T Houseman, Walter Finkbeiner, Kevan M Shokat and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Role of MicroRNA in the Airway Surface Liquid Homeostasis.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Neuronal Wiskott-Aldrich syndrome protein regulates TGF-β1-mediated lung vascular permeability.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Pulmonary microRNA profiling in a mouse model of ventilator-induced lung injury.American journal of physiology. Lung cellular and molecular physiology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Jérémie RouxLaboratory of Surgical Research, Department of Anesthesia, University of California, San Francisco, California 94110, USA. Jeremie.Roux@gmail.com
Michel Carles
Hidefumi Koh
Arnaud Goolaerts
Michael T Ganter
Brian B Chesebro
Marybeth Howard
Benjamin T Houseman
Walter Finkbeiner
Kevan M Shokat
Agnès C Paquet
Michael A Matthay
Jean-François Pittet
University of California, San Francisco · USInserm · FR

Funding

Therapy for Clinical Acute Lung Injury with APCP50HL074005 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2003 to 2007
$9.6M
Comprehensive Anesthesia Research TrainingT32GM008440 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Judith Hellman · 1996 to 2026
$5.5M
MECHANISMS OF ALVEOLAR EPITHELIAL FLUID CLEARANCER01HL051854 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 1994 to 2012
$4.4M
Resolution of Clinical Lung InjuryR37HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 2006 to 2015
$3.9M
RESOLUTION OF CLINICAL LUNG INJURYR01HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 1996 to 2005
$1.7M
NHLBI NIH HHS HL-51854NHLBI NIH HHS HL-51856NHLBI NIH HHS P50 HL074005NHLBI NIH HHS P50HL074005NHLBI NIH HHS R01 HL051854NHLBI NIH HHS R01 HL051856NHLBI NIH HHS R37 HL051856NIGMS NIH HHS T32 GM008440
6 · The paper itself

Abstract

Exogenous or endogenous beta(2)-adrenergic receptor agonists enhance alveolar epithelial fluid transport via a cAMP-dependent mechanism that protects the lungs from alveolar flooding in acute lung injury. However, impaired alveolar fluid clearance is present in most of the patients with acute lung injury and is associated with increased mortality, although the mechanisms responsible for this inhibition of the alveolar epithelial fluid transport are not completely understood. Here, we found that transforming growth factor beta1 (TGF-beta1), a critical mediator of acute lung injury, inhibits beta(2)-adrenergic receptor agonist-stimulated vectorial fluid and Cl(-) transport across primary rat and human alveolar epithelial type II cell monolayers. This inhibition is due to a reduction in the cystic fibrosis transmembrane conductance regulator activity and biosynthesis mediated by a phosphatidylinositol 3-kinase (PI3K)-dependent heterologous desensitization and down-regulation of the beta(2)-adrenergic receptors. Consistent with these in vitro results, inhibition of the PI3K pathway or pretreatment with soluble chimeric TGF-beta type II receptor restored beta(2)-adrenergic receptor agonist-stimulated alveolar epithelial fluid transport in an in vivo model of acute lung injury induced by hemorrhagic shock in rats. The results demonstrate a novel role for TGF-beta1 in impairing the beta- adrenergic agonist-stimulated alveolar fluid clearance in acute lung injury, an effect that could be corrected by using PI3K inhibitors that are safe to use in humans.

Indexed as

Adrenergic beta-2 Receptor AntagonistsAnimalsBiological TransportBlotting, WesternCells, CulturedCell SurvivalChloridesCyclic AMPCystic Fibrosis Transmembrane Conductance RegulatorEpithelial CellsHumansMalePhosphatidylinositol 3-KinasesPulmonary AlveoliRatsRats, Sprague-DawleyAdrenergic beta-2 Receptor AntagonistsChloridesCyclic AMPCystic Fibrosis Transmembrane Conductance RegulatorPhosphatidylinositol 3-KinasesReceptors, Adrenergic, beta-2Transforming Growth Factor beta1

Identifiers

PMID19996317
PMCPMC2836032
OpenAlexW1981685902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.